The White House withdrew Dr. Heidi Overton’s nomination to lead the Food and Drug Administration on Tuesday night, hours before a Senate committee vote where Republican support had eroded over her positions on vaccines, abortion and vaping.
President Donald Trump nominated Overton, a physician and deputy director of the White House Domestic Policy Council, in August to succeed Dr. Marty Makary, who resigned in May after clashes with the White House over fruit-flavored vape authorizations. The Senate Health, Education, Labor and Pensions Committee was scheduled to vote Wednesday. Overton needed all 12 Republicans on the 21-member panel to advance; Democrats hold the other 11 seats.
Republican opposition centered on three issues
The committee chair and a physician, Sen. Bill Cassidy, R-La., had called Overton’s support for Trump’s plan to break up combination vaccines — including the measles, mumps and rubella shot — “almost disqualifying”. At her September confirmation hearing, Cassidy pressed her on whether she would push back against Trump and Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic. Overton testified that the MMR vaccine is safe and effective.
Tonight, the White House abandoned a viable confirmation path for Dr. Overton. The WH said that this was because she did not have the votes to pass. This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee…
Democrats and some Republicans also questioned Overton’s record on abortion. In a 2023 policy brief, she criticized expanded access to abortion pills while working at the conservative America First Policy Institute.
At her hearing, she declined to say whether the abortion drug mifepristone is safe and effective, despite decades of FDA approval and peer-reviewed evidence. Sen. Patty Murray of Washington said Overton “would not say what the science has said for years now: that the abortion pill is safe and effective”.
Breaking news: The White House is abandoning the nomination of Heidi Overton to lead the FDA amid growing concerns that she could not be confirmed by the Senate. https://t.co/JWHZ1WjVpd
Vaping policy drew scrutiny after reports that Overton worked to relax standards on fruit-flavored vapes. Calley Means alleged on a podcast that Overton advanced vaping industry interests and worked with the Justice Department to construct a legal argument for supporting liability protections for pesticide companies.
Cassidy claims votes existed; White House references vote count
After the withdrawal, Cassidy posted on X that he believed Overton “would have had the votes to pass out of committee and pass the full Senate”. He wrote that anti-abortion senators had sought final assurances from the administration on “life issues” and “the Administration withdrew Dr. Overton rather than make such commitments”. A White House official told CNN the decision came after officials saw skepticism from multiple Senate Republicans.
Sen. Bill Cassidy tells me "story's pending" when asked if he plans to still hold a vote on Overton tomorrow. https://t.co/booFLsS4vB
Sen. Susan Collins of Maine, a Republican who supports abortion rights, had not committed to voting for Overton. She lost her reelection bid earlier this month. Sen. Josh Hawley, R-Mo., had also withheld support, saying he had further questions about the FDA’s mifepristone safety review.
FDA remains without a permanent leader
The agency has been led since May by acting commissioner Kyle Diamantas, an attorney and friend of Donald Trump Jr. It was not immediately clear when, or if, the White House might put forward another FDA nominee. Republicans control the Senate only until January, when Democrats take the majority.

Reproductive rights groups celebrate withdrawal
The Reproductive Freedom Alliance, a coalition of two dozen governors, had urged the Senate to halt consideration of Overton’s nomination until the new Congress takes office.
“Earlier this month, voters elected candidates who champion reproductive freedom up and down the ballot, yet the current Senate is moving to fast-track a nominee with a long record of working to restrict abortion access”, the alliance said. Mini Timmaraju, president and CEO of Reproductive Freedom for All, called Overton “a serious threat to the future of medication abortion access”.
Trump’s nominee to lead the FDA, Heidi Overton, has been involved in nearly every major health decision made by this admin. To learn more about her potential priorities at the FDA, we FOIAed communications between her and HHS officials. pic.twitter.com/CP9ELM2eZQ
“Confirmation is not a coronation”, said Erik Baptist, senior vice president for legal strategy at SBA Pro-Life America. “It is a time to vet nominees and seek commitments before they take office.” The FDA has promised a report on its mifepristone safety review by March.
🚩As Trump’s pick for FDA head, extremist Heidi Overton would have power over restrictions on medication abortion, and we know exactly what she plans to do with it. We CANNOT let her confirmation go through. Tell your senators now: Vote NO on Heidi Overton.https://t.co/OU5YtexY8y
More on Robert F. Kennedy Jr.
News: Sen. Roger Marshall is under consideration to be the FDA nominee as Heidi Overton's nomination is now highly unlikely to succeed, according to four people familiar Admin + Republicans want a confirmation in the lame duck and Marshall seen as one of the few people who could…
White House pulls Heidi Overton’s nomination to run FDA amid bipartisan criticism and some second thoughts by Trump officials. With @rachel_roubein and confirming @axiosalex who had it first.https://t.co/G37iWWoEL4
The White House has pulled Dr. Heidi Overton's nomination to lead the FDA in the face of Senate opposition to her candidacy, a White House official confirmed. https://t.co/1bGWGjEke1
The White House has pulled Dr. Heidi Overton's nomination to lead the FDA in the face of Senate opposition to her candidacy, according to a White House official and two sources familiar with the matter. https://t.co/oxIzXrOSSi pic.twitter.com/6otiBsnX9y
Dr. Heidi Overton’s nomination to lead the Food and Drug Administration was dropped on Tuesday, a White House official confirmed to ABC News. Read more: https://t.co/oobI2rEEGl pic.twitter.com/YPSdHLwlNO
UPDATE: The White House has dropped the nomination of Heidi Overton to lead the FDA, a senior administration official and other people familiar with the decision tell @cbsnews’s @margbrennan and me. https://t.co/i6WGkblIuw